GDF15 and colon adenocarcinoma: Our results may support the use of miR-216a and GDF15 as diagnostic/prognostic biomarkers for COAD, further clarify the molecular basis underlying immunomodulation, mitochondrial organization, and apoptotic signaling and reveal Gemcitabine as a potential precision treatment for COAD.